LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX
· Real-Time Price · USD
1.52
-0.02 (-1.30%)
At close: Aug 15, 2025, 3:59 PM
1.52
-0.33%
After-hours: Aug 15, 2025, 04:04 PM EDT
LAVA Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 39.67M | 35.02M | 26.96M | 35.09M | 43.19M | 44.23M | 62.66M | 87.61M | 100.6M | 100.33M | 64.33M | 75.87M | 85.72M | 151.01M | 116.49M | 181.22M | 185.79M |
Short-Term Investments | 26.88M | 41.56M | 51.92M | 51.71M | 51.39M | 51.34M | 41.96M | 24.8M | 24.83M | 32.53M | 28.39M | 34.85M | 38.43M | 47.99M | 48.68M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.71M | n/a | n/a |
Other Long-Term Assets | 95K | 91K | 114K | 144K | 256K | 319K | 326K | 346K | 982K | 809K | 711K | 718K | 750K | 902.43K | 814.5K | 864.08K | 843.84K |
Receivables | n/a | n/a | 1.02M | 1.15M | 907K | 1.7M | 1.38M | 3.99M | 2.02M | 3.25M | 53.02M | 834K | 889K | 734K | 1.97M | 744.95K | 656.99K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 246K | 262K | 2.00 | 2.27 | 2.87M | 3.08M | 92K |
Other Current Assets | 1.66M | 1.65M | 1.63M | 2.22M | n/a | 1.63M | n/a | 2.12M | n/a | n/a | n/a | 262K | n/a | n/a | 1.66M | 2.36M | 533.99K |
Total Current Assets | 69.78M | 79.3M | 81.54M | 90.17M | 96.67M | 98.9M | 107.92M | 118.52M | 130.61M | 140.53M | 147.6M | 112.79M | 126.69M | 154.76M | 172.25M | 187.98M | 187.19M |
Property-Plant & Equipment | 1.28M | 1.44M | 1.71M | 1.97M | 2.15M | 2.49M | 2.78M | 3.68M | 3.69M | 2.08M | 1.58M | 1.8M | 2.07M | 2.21M | 2.23M | 1.64M | 1.72M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.71M | n/a | n/a |
Total Long-Term Assets | 1.38M | 1.53M | 1.82M | 2.11M | 2.41M | 2.81M | 3.1M | 4.02M | 4.67M | 2.89M | 2.29M | 2.52M | 2.82M | 3.11M | 3.06M | 2.52M | 2.59M |
Total Assets | 71.16M | 80.83M | 83.36M | 92.28M | 99.08M | 101.71M | 111.02M | 122.54M | 135.28M | 143.43M | 149.89M | 115.31M | 129.51M | 157.87M | 175.31M | 190.5M | 189.77M |
Account Payables | 1.52M | 2.72M | 2.81M | 4.16M | 3.44M | 4.45M | 9.38M | 5.07M | 3.12M | 3.96M | 7.8M | 2.93M | 2.66M | 2.55M | 1.91M | 2.17M | 1.72M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 2.00 | n/a | n/a | n/a | 35M | n/a | n/a | 485K | 1.73M | 3.07M | 4.54M | 5.03M |
Short-Term Debt | n/a | 4.89M | 5.76M | 5.38M | 5.29M | 5.28M | 4.94M | 4.95M | 4.85M | 4.64M | n/a | n/a | n/a | n/a | -2.09M | -1.87M | n/a |
Other Current Liabilities | 2.49M | 949K | n/a | n/a | n/a | 3.3M | n/a | n/a | 4.83M | 11.07M | 4.36M | 9.25M | 9.87M | 6.75M | 5.15M | 5.53M | 12.27M |
Total Current Liabilities | 10.37M | 18.01M | 15.2M | 14.11M | 13.03M | 14.94M | 20.75M | 22.33M | 23.57M | 21.95M | 17.86M | 16.73M | 16.34M | 5.02M | 15.08M | 16.27M | 22.18M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.17M | 4.33M | 4.51M | 4.28M | 4.08M | 3.88M | 3.53M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 5.03M | 5.15M | 7.02M | 6.87M |
Total Long-Term Liabilities | 35.01M | 35.08M | 35.16M | 35.3M | 35.39M | 35.59M | 35.67M | 36.32M | 36.43M | 35.43M | 39.37M | 4.54M | 4.76M | 18.65M | 11.08M | 11.04M | 11.13M |
Total Liabilities | 45.37M | 53.09M | 50.36M | 49.41M | 48.41M | 50.53M | 56.42M | 58.65M | 60.01M | 57.38M | 57.23M | 21.27M | 21.1M | 23.67M | 26.16M | 27.31M | 33.32M |
Total Debt | 312K | 5.28M | 6.29M | 6.16M | 6.13M | 6.31M | 6.2M | 6.95M | 6.98M | 5.45M | 4.63M | 4.83M | 5.1M | 5.52M | 5.5M | 5.12M | 4.68M |
Common Stock | 3.72M | 3.72M | 3.72M | 3.72M | 3.71M | 3.71M | 3.71M | 3.71M | 3.71M | 3.71M | 3.71M | 3.66M | 3.65M | 4.14M | 4.16M | 4.37M | 4.16M |
Retained Earnings | -178.45M | -174.97M | -168.93M | -156.72M | -148.48M | -148.07M | -141.91M | -134.71M | -122.01M | -108.07M | -93.46M | -94.46M | -89.29M | -89.26M | -79.74M | -73.09M | -63.4M |
Comprehensive Income | -11.68M | -12.65M | -10.6M | -12.29M | 997K | 1.11M | -1.63M | 463K | -854K | -4.03M | -12.02M | -7.44M | 1.77M | 1.33M | 5.52M | 2.04M | 2.04M |
Shareholders Equity | 25.78M | 27.75M | 32.99M | 42.88M | 50.66M | 51.18M | 54.6M | 63.89M | 75.28M | 86.04M | 92.66M | 94.04M | 108.41M | 134.19M | 149.14M | 163.2M | 156.46M |
Total Investments | 26.88M | 41.56M | 51.92M | 51.71M | 51.39M | 51.34M | 41.96M | 24.8M | 24.83M | 32.53M | 28.39M | 34.85M | 38.43M | 47.99M | 41.97M | n/a | n/a |